Image available on the official notice.
Guidance "秘実S" - Safety alert
Official notice
21 Feb 2019
Last checked
27 Oct 2026
An official CAA Japan notice concerns Guidance "秘実S" - Safety alert. Violation of the provisions of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. ■Background: Analysis by the Kawasaki City Institute for Public Health of a so-called health food purchased by Kawasaki City for testing detected tadalafil, a pharmaceutical ingredient used to treat erectile dysfunction and other conditions. This product containing tadalafil qualifies as a pharmaceutical under Article 2, paragraph 1 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter the "Pharmaceuticals and Medical Devices Act"). Selling this product violates Article 55, paragraph 2 of that Act (prohibition on the sale, supply, etc. of unapproved and unlicensed pharmaceuticals). Published 2019-02-21.
What to do now
■Kawasaki City's response: We are instructing the store where the product was purchased to recall the product and take other measures. We have also asked the Tokyo Metropolitan Government, which has jurisdiction over the seller, to provide guidance and take measures concerning the violation of the Pharmaceuticals and Medical Devices Act. We will post information about the product on the city's website to alert the public.
Official notice
2019-02-21
The hazard
The hazard
Violation of the provisions of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. ■Background: Analysis by the Kawasaki City Institute for Public Health of a so-called health food purchased by Kawasaki City for testing detected tadalafil, a pharmaceutical ingredient used to treat erectile dysfunction and other conditions. This product containing tadalafil qualifies as a pharmaceutical under Article 2, paragraph 1 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter the "Pharmaceuticals and Medical Devices Act"). Selling this product violates Article 55, paragraph 2 of that Act (prohibition on the sale, supply, etc. of unapproved and unlicensed pharmaceuticals).
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Best Before Dates
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: ガイダンス. Contact: 【注意喚起】.
Source & status
Source & status
Recall details
Recall details
Event id
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.